American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

RSS icon

VIDEO: How to implant a Linq implantable cardiac monitor

The Medtronic Linq and Linq II implantable cardiac monitors (ICM) have become some of the most popular ICM devices on the market, partly because they are easy to insert.

American College of Cardiology (ACC) President Edward T. A. Fry, MD, FACC, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, and chair of the Ascension National Cardiovascular Service Line, discusses healthcare disparities that became very pronounced during the COVID-19 pandemic. He said this is an issue that was really brought to the forefront during the pandemic and it was clear outcomes with minorities were impacted by their ability to pay, access to care.

VIDEO: ACC President Edward Fry outlines disparities in care seen during the pandemic

In a recent interview with Cardiovascular Business, ACC President Edward T. A. Fry, MD, discussed some of the healthcare disparities that were highlighted during the COVID-19 pandemic. 

COVID-19 can have a serious impact effecting the heart during and after infection. The ACC released expert consensus decision pathway for the evaluation and management for the cardiovascular consequences of COVID infection and long-COVID, also known by its official clinical designation as post-acute sequelae of SARS-CoV-2 infection (PASC).

VIDEO: ACC Guidance on the cardiovascular impact of COVID-19

Ty Gluckman, MD, explains the main points of the American College of Cardiology (ACC) expert consensus on the cardiovascular consequences stemming from a COVID-19 infection.

Edward Fry, MD, is the 2022-23 ACC president.

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 

The American College of Cardiology (ACC) annual meeting is the premier source for the latest cardiac science. #ACC22

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

VIDEO: TAVR durability outperforms surgical valves

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

Several ACC 2022 late-breaking trials may have impacts on clinical practice for interventional cardiology and structural heart. One trial compared FFR vs. IVUS guided PCI for intermediate coronary lesions. Photos by Dave Fornell

Key interventional cardiology takeaways from ACC.22

Several late-breaking clinical trials at ACC.22 will likely impact clinical practice. Below are summaries of a few key trials and their takeaways for interventional cardiology and structural heart interventions. 

Displaying 233 - 240 of 275
Design by Adaptive Theme